Evaxion Long Term Debt vs Short Term Investments Analysis

EVAX Stock  USD 1.17  0.02  1.68%   
Evaxion Biotech financial indicator trend analysis is much more than just examining Evaxion Biotech AS latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evaxion Biotech AS is a good investment. Please check the relationship between Evaxion Biotech Long Term Debt and its Short Term Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Long Term Debt vs Short Term Investments

Long Term Debt vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evaxion Biotech AS Long Term Debt account and Short Term Investments. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Evaxion Biotech's Long Term Debt and Short Term Investments is -0.66. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Evaxion Biotech AS, assuming nothing else is changed. The correlation between historical values of Evaxion Biotech's Long Term Debt and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Evaxion Biotech AS are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Long Term Debt i.e., Evaxion Biotech's Long Term Debt and Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.66
Relationship DirectionNegative 
Relationship StrengthWeak

Long Term Debt

Long-term debt is a debt that Evaxion Biotech AS has held for over one year. Long-term debt appears on Evaxion Biotech AS balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Evaxion Biotech AS balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Short Term Investments

Short Term Investments is an item under the current assets section of Evaxion Biotech balance sheet. It contains any investments Evaxion Biotech AS undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Evaxion Biotech AS can easily liquidate in the marketplace.
Most indicators from Evaxion Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evaxion Biotech AS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Issuance Of Capital Stock is likely to rise to about 15.2 M in 2024, whereas Tax Provision is likely to drop (825.3 K) in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization343.5K571.3K615.9K330.1K
Interest Income2.0M2.8M2.3M1.4M

Evaxion Biotech fundamental ratios Correlations

0.190.130.140.43-0.07-0.150.050.120.24-0.01-0.240.240.25-0.08-0.24-0.090.09-0.090.160.290.170.060.00.010.88
0.190.850.81-0.160.510.24-0.780.410.250.390.640.25-0.67-0.60.710.530.180.890.110.36-0.090.470.680.640.02
0.130.850.62-0.160.590.18-0.940.640.230.60.750.23-0.62-0.640.890.590.420.90.090.350.0-0.010.830.85-0.06
0.140.810.62-0.260.48-0.05-0.60.590.450.560.530.45-0.77-0.830.540.460.470.790.340.450.10.680.580.56-0.11
0.43-0.16-0.16-0.26-0.830.650.48-0.46-0.72-0.6-0.71-0.720.350.43-0.53-0.82-0.34-0.47-0.77-0.7-0.720.01-0.48-0.580.79
-0.070.510.590.48-0.83-0.51-0.810.710.760.790.930.76-0.44-0.60.781.00.470.740.720.790.67-0.090.860.86-0.49
-0.150.240.18-0.050.65-0.510.04-0.42-0.88-0.45-0.21-0.880.030.380.01-0.47-0.410.03-0.93-0.81-0.970.12-0.12-0.330.26
0.05-0.78-0.94-0.60.48-0.810.04-0.73-0.41-0.74-0.92-0.410.630.67-0.98-0.81-0.49-0.94-0.31-0.51-0.230.07-0.92-0.940.33
0.120.410.640.59-0.460.71-0.42-0.730.610.980.670.61-0.4-0.770.690.660.930.660.550.610.51-0.120.730.81-0.23
0.240.250.230.45-0.720.76-0.88-0.410.610.640.521.0-0.35-0.670.330.720.490.40.990.980.930.110.460.63-0.25
-0.010.390.60.56-0.60.79-0.45-0.740.980.640.730.64-0.38-0.720.730.740.910.680.60.630.56-0.130.730.81-0.38
-0.240.640.750.53-0.710.93-0.21-0.920.670.520.730.52-0.59-0.60.920.940.40.870.460.570.38-0.060.940.89-0.55
0.240.250.230.45-0.720.76-0.88-0.410.611.00.640.52-0.35-0.670.330.720.490.40.990.980.930.110.460.63-0.25
0.25-0.67-0.62-0.770.35-0.440.030.63-0.4-0.35-0.38-0.59-0.350.84-0.64-0.43-0.25-0.77-0.25-0.36-0.07-0.49-0.54-0.650.44
-0.08-0.6-0.64-0.830.43-0.60.380.67-0.77-0.67-0.72-0.6-0.670.84-0.62-0.55-0.66-0.75-0.58-0.66-0.43-0.35-0.62-0.790.28
-0.240.710.890.54-0.530.780.01-0.980.690.330.730.920.33-0.64-0.620.780.480.930.240.420.17-0.10.870.91-0.48
-0.090.530.590.46-0.821.0-0.47-0.810.660.720.740.940.72-0.43-0.550.780.40.740.690.760.63-0.090.870.84-0.49
0.090.180.420.47-0.340.47-0.41-0.490.930.490.910.40.49-0.25-0.660.480.40.450.460.470.44-0.130.430.59-0.2
-0.090.890.90.79-0.470.740.03-0.940.660.40.680.870.4-0.77-0.750.930.740.450.290.490.130.250.840.86-0.36
0.160.110.090.34-0.770.72-0.93-0.310.550.990.60.460.99-0.25-0.580.240.690.460.290.950.960.070.360.54-0.31
0.290.360.350.45-0.70.79-0.81-0.510.610.980.630.570.98-0.36-0.660.420.760.470.490.950.890.070.50.71-0.2
0.17-0.090.00.1-0.720.67-0.97-0.230.510.930.560.380.93-0.07-0.430.170.630.440.130.960.89-0.190.30.49-0.28
0.060.47-0.010.680.01-0.090.120.07-0.120.11-0.13-0.060.11-0.49-0.35-0.1-0.09-0.130.250.070.07-0.19-0.09-0.130.04
0.00.680.830.58-0.480.86-0.12-0.920.730.460.730.940.46-0.54-0.620.870.870.430.840.360.50.3-0.090.87-0.29
0.010.640.850.56-0.580.86-0.33-0.940.810.630.810.890.63-0.65-0.790.910.840.590.860.540.710.49-0.130.87-0.36
0.880.02-0.06-0.110.79-0.490.260.33-0.23-0.25-0.38-0.55-0.250.440.28-0.48-0.49-0.2-0.36-0.31-0.2-0.280.04-0.29-0.36
Click cells to compare fundamentals

Evaxion Biotech Account Relationship Matchups

Evaxion Biotech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets11.1M12.0M40.2M(58.9M)12.9M13.5M
Short Long Term Debt Total36K20K3.7M2.3M10.9M11.4M
Other Current Liab1.0M1.2M1.0M1.2M3.9M4.1M
Total Current Liabilities1.7M4.9M4.3M3.8M7.1M5.0M
Total Stockholder Equity9.4M7.0M(50.4M)(72.7M)(4.7M)(5.0M)
Property Plant And Equipment Net126K457K5.4M4.7M4.3M2.4M
Net Debt(9.5M)(5.8M)(28.5M)(10.9M)5.3M5.6M
Retained Earnings(15.8M)(27.3M)(50.4M)(72.7M)(108.0M)(102.6M)
Accounts Payable646K3.7M2.8M2.1M2.7M1.9M
Cash9.6M5.8M32.2M13.2M5.6M5.3M
Non Current Assets Total126K6.1M5.5M5.0M4.5M3.4M
Cash And Short Term Investments9.6M5.8M32.2M13.2M5.6M5.3M
Net Receivables931K1.8M1.9M789K1.1M1.1M
Liabilities And Stockholders Equity11.1M12.0M(42.7M)(58.9M)12.9M13.5M
Non Current Liabilities Total682K2.7M3.4M10.0M10.5M11.1M
Capital Lease Obligations36K20K2.5M2.3M2.2M1.1M
Other Current Assets468.0K6.3M3.2M2.5M1.7M2.3M
Total Liab1.7M4.9M7.7M13.7M17.6M18.5M
Net Invested Capital9.4M7.0M33.6M16.3M3.9M3.7M
Total Current Assets11.0M5.8M34.7M14.0M8.4M13.3M
Accumulated Other Comprehensive Income22.7M31.7M79.1M(3.7M)(3.8M)(3.6M)
Net Working Capital9.2M6.0M30.4M13.2M1.3M1.2M
Short Term Debt36K40K440K439K485K460.8K
Common Stock2.5M2.6M3.8M3.9M5.9M3.6M
Other Assets25K694K191K(78.0M)134.0140.7
Inventory(6.0)(6.9M)(1.9M)(2.5M)(2.2M)(2.4M)
Other Stockholder Equity(169K)34.3M(82.9M)80.7M101.1M106.2M
Capital Stock2.5M2.6M3.8M3.9M5.9M3.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.